SCHEMBL19407002

SCHEMBL19407002

COc1ccc(I)c(Cl)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
S1PR4 O95977 1/20 0.40
HSP90AA1 P07900 1/20 0.40
MAPT P10636 1/20 0.40
G6PD P11413 1/20 0.40
S1PR1 P21453 1/20 0.40
MAPK1 P28482 1/20 0.40
OPRK1 P41145 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
MCL1 Q07820 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
TLR9 Q9NR96 1/20 0.40
ALDH1A1 P00352 8/20 0.40
LMNA P02545 1/20 0.40
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14339474 0.84 KDM4E (0.50) KDM4ES1PR4HSP90AA1MAPTG6PD
SCHEMBL29979596 0.82 AMY1A (0.39) KDM4ES1PR4HSP90AA1MAPTG6PD
SCHEMBL12381475 0.82 AMY1A (0.39) KDM4ES1PR4HSP90AA1MAPTG6PD
SCHEMBL27731713 0.80 KDM4E (0.37) KDM4ES1PR4HSP90AA1MAPTG6PD
SCHEMBL16704713 0.80 MAPT (0.43) KDM4ES1PR4HSP90AA1MAPTG6PD
SCHEMBL4619216 0.79 CA1 (0.46) KDM4EMAPTMAPK1HTTRAB9A
SCHEMBL22993287 0.78 CA12 (0.48) KDM4EMAPTMAPK1HTTRAB9A
SCHEMBL16180685 0.76 NOTUM (0.48) LMNANOTUM
SCHEMBL30715275 0.75 ALDH1A1 (0.46) KDM4ES1PR4HSP90AA1MAPTG6PD
SCHEMBL53547 0.75 ALDH1A1 (0.46) KDM4ES1PR4HSP90AA1MAPTG6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 WO disclosed